Phreesia EBITDA Margin 2019-2025 | PHR
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Phreesia (PHR) over the last 10 years. The current EBITDA margin for Phreesia as of April 30, 2025 is .
| Phreesia EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-04-30 | $0.44B | $-0.01B | -2.76% |
| 2025-01-31 | $0.42B | $-0.03B | -6.67% |
| 2024-10-31 | $0.41B | $-0.05B | -11.85% |
| 2024-07-31 | $0.39B | $-0.07B | -17.18% |
| 2024-04-30 | $0.37B | $-0.09B | -23.26% |
| 2024-01-31 | $0.36B | $-0.11B | -29.41% |
| 2023-10-31 | $0.34B | $-0.12B | -34.22% |
| 2023-07-31 | $0.32B | $-0.13B | -39.06% |
| 2023-04-30 | $0.30B | $-0.14B | -44.70% |
| 2023-01-31 | $0.28B | $-0.15B | -53.02% |
| 2022-10-31 | $0.26B | $-0.16B | -59.92% |
| 2022-07-31 | $0.25B | $-0.15B | -62.86% |
| 2022-04-30 | $0.23B | $-0.13B | -57.89% |
| 2022-01-31 | $0.21B | $-0.09B | -43.66% |
| 2021-10-31 | $0.20B | $-0.06B | -28.93% |
| 2021-07-31 | $0.18B | $-0.03B | -16.20% |
| 2021-04-30 | $0.16B | $-0.01B | -7.36% |
| 2021-01-31 | $0.15B | $-0.01B | -5.41% |
| 2020-10-31 | $0.14B | $0.00B | -2.88% |
| 2020-07-31 | $0.13B | 0 | 0.00% |
| 2020-04-30 | $0.13B | $0.00B | 0.77% |
| 2020-01-31 | $0.13B | $0.00B | 1.60% |
| 2019-07-31 | $0.08B | $0.00B | 1.19% |
| 2019-04-30 | $0.08B | 0 | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.689B | $0.420B |
| Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.919B | 58.42 |
| Doximity (DOCS) | United States | $11.431B | 52.92 |
| Hims & Hers Health (HIMS) | United States | $10.838B | 112.61 |
| Tempus AI (TEM) | United States | $10.042B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.445B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.743B | 58.48 |
| Hinge Health (HNGE) | United States | $3.360B | 0.00 |
| Privia Health (PRVA) | United States | $2.603B | 177.92 |
| Enovis (ENOV) | United States | $1.886B | 10.52 |
| Schrodinger (SDGR) | United States | $1.514B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.471B | 0.00 |
| 10x Genomics (TXG) | United States | $1.468B | 0.00 |
| Azenta (AZTA) | United States | $1.439B | 66.87 |
| Evolent Health (EVH) | United States | $1.367B | 116.40 |
| Omnicell (OMCL) | United States | $1.355B | 23.90 |
| Claritev (CTEV) | United States | $0.794B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.587B | 0.00 |
| Veradigm (MDRX) | United States | $0.536B | 0.00 |
| Standard BioTools (LAB) | United States | $0.486B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.465B | 0.00 |
| Talkspace (TALK) | United States | $0.443B | 132.50 |
| Outset Medical (OM) | United States | $0.362B | 0.00 |
| TruBridge (TBRG) | United States | $0.340B | 754.67 |
| Health Catalyst (HCAT) | United States | $0.275B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.268B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.217B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.169B | 0.00 |
| American Well (AMWL) | United States | $0.127B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.124B | 0.00 |
| Pulmonx (LUNG) | United States | $0.106B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.101B | 0.00 |
| CareCloud (CCLD) | United States | $0.100B | 3.81 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.087B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.075B | 0.00 |
| 111 (YI) | China | $0.065B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.050B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.046B | 0.00 |
| HeartBeam (BEAT) | United States | $0.044B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |